NorthCrest Asset Manangement LLC bought a new stake in Apollo Medical Holdings, Inc. (NASDAQ:AMEH – Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 199,931 shares of the company’s stock, valued at approximately $7,291,000. NorthCrest Asset Manangement LLC owned about 0.35% of Apollo Medical at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. FMR LLC increased its position in shares of Apollo Medical by 36.1% during the second quarter. FMR LLC now owns 1,067 shares of the company’s stock worth $41,000 after acquiring an additional 283 shares during the last quarter. South Dakota Investment Council increased its position in shares of Apollo Medical by 7.1% during the fourth quarter. South Dakota Investment Council now owns 5,356 shares of the company’s stock worth $158,000 after acquiring an additional 356 shares during the last quarter. State of Alaska Department of Revenue increased its position in shares of Apollo Medical by 1.7% during the fourth quarter. State of Alaska Department of Revenue now owns 27,648 shares of the company’s stock worth $818,000 after acquiring an additional 469 shares during the last quarter. Arizona State Retirement System increased its position in shares of Apollo Medical by 4.6% during the fourth quarter. Arizona State Retirement System now owns 11,152 shares of the company’s stock worth $330,000 after acquiring an additional 490 shares during the last quarter. Finally, PNC Financial Services Group Inc. increased its position in shares of Apollo Medical by 49.9% during the first quarter. PNC Financial Services Group Inc. now owns 1,563 shares of the company’s stock worth $75,000 after acquiring an additional 520 shares during the last quarter. Institutional investors and hedge funds own 34.63% of the company’s stock.
Analyst Upgrades and Downgrades
Separately, Bank of America assumed coverage on Apollo Medical in a report on Wednesday, April 12th. They issued a “neutral” rating and a $44.00 price objective for the company.
Apollo Medical Price Performance
Apollo Medical (NASDAQ:AMEH – Free Report) last posted its quarterly earnings results on Monday, May 8th. The company reported $0.42 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.07. Apollo Medical had a net margin of 4.06% and a return on equity of 10.98%. The business had revenue of $337.24 million for the quarter, compared to the consensus estimate of $331.60 million. Equities analysts expect that Apollo Medical Holdings, Inc. will post 1.19 earnings per share for the current fiscal year.
About Apollo Medical
Apollo Medical Holdings, Inc, a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
See Also
- Five stocks we like better than Apollo Medical
- Commercial Metals Winning Infrastructure and Datacenter Customers
- Biogen Shares Fall After FDA Approval Of Alzheimer’s Drug Leqembi
- Shell’s Production Outlook: Not as Bad as Expected?
- Tyson Foods Becomes a Value Play, Cyclical Bull Run Coming
- Enphase Energy is Still Converting Solar Energy into Profits
Want to see what other hedge funds are holding AMEH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Apollo Medical Holdings, Inc. (NASDAQ:AMEH – Free Report).
Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.
